Watson Pharma Inc. (WPI) confirmed that its subsidiary, Watson Laboratories Inc., has filed an Abbreviated New Drug Application with the U.S. FDA seeking approval to market its lidocaine topical patch 8% prior to the expiration of U.S. Patent No. 5,827,529.
Watson's lidocaine topical patch 8% is a generic version of Endo's Lidoderm.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.